Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration.
about
Epidemiological and Clinical Baseline Characteristics as Predictive Biomarkers of Response to Anti-VEGF Treatment in Patients with Neovascular AMDManagement of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in developmentA view of the current and future role of optical coherence tomography in the management of age-related macular degeneration.Short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation.Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).Stereotactic radiotherapy in neovascular age-related macular degeneration: Real-life efficacy and morphological evaluation of the outer retina-choroid complex.Relationships of orientation discrimination threshold and visual acuity with macular lesions in age-related macular degeneration.Optical coherence tomography: A guide to interpretation of common macular diseases.Ranibizumab for vascularized pigment epithelial detachment: 1-year anatomic and functional results.Inner nuclear layer cystoid spaces are a poor prognostic factor in typical age-related macular degeneration and polypoidal choroidal vasculopathy.Comparison of Short-Term Choroidal Thickness and Retinal Morphological Changes after Intravitreal Anti-VEGF Therapy with Ranibizumab or Aflibercept in Treatment-Naive Eyes.The potential of spectral domain optical coherence tomography imaging based retinal biomarkers.Intraretinal cysts are the most relevant prognostic biomarker in neovascular age-related macular degeneration independent of the therapeutic strategy.Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance.Conversion back to bevacizumab or ranibizumab for recurrent neovascular activity with aflibercept in age-related macular degeneration: a case series.Optical coherence tomography findings as a predictor of clinical course in patients with branch retinal vein occlusion treated with ranibizumab.
P2860
Q26748731-E93B8681-7259-49A8-8735-B1FDF7352035Q26824335-7783EE83-540E-4183-8D86-3B768BE39071Q30240689-829C6C3E-41B6-4430-9169-8DC4D17FDC45Q33846379-58A3CF2A-C0F3-4A7A-A469-7D34FB6CC847Q34092454-663F6772-975F-4C81-9F64-7F8D558FC6D7Q37552180-6D64AF56-EB06-4504-AA23-EEC7CEFA0D47Q41702424-ACC287D9-03E5-4D50-A1AA-F1FF2F005FDEQ47570944-ED7A0D1B-8B52-423A-A559-160F42F021FCQ47616707-996F4BC8-643A-42A7-AFC5-757CE91EA92CQ47936744-AAE835F0-D294-45D5-A7BF-A37780B8C50BQ48252782-5259D27E-1CF7-43F2-9D9C-FFEBF91D8FD0Q50791101-9D5C90ED-333B-47F3-BFB4-9CB0365A0EFAQ51065299-59004435-B230-45AA-A034-FA1D5E3A9CEAQ52595306-8F5C638C-CCEF-417E-8B73-BD84E1C6A60EQ54171873-CF6FAB3A-DE66-4337-9149-7E779295234EQ55442786-13BCFFE8-796D-4365-BE2C-C38E197A16F6
P2860
Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Morphologic parameters relevan ...... -related macular degeneration.
@ast
Morphologic parameters relevan ...... -related macular degeneration.
@en
type
label
Morphologic parameters relevan ...... -related macular degeneration.
@ast
Morphologic parameters relevan ...... -related macular degeneration.
@en
prefLabel
Morphologic parameters relevan ...... -related macular degeneration.
@ast
Morphologic parameters relevan ...... -related macular degeneration.
@en
P2093
P1433
P1476
Morphologic parameters relevan ...... -related macular degeneration.
@en
P2093
Christian Simader
Gabor G Deák
Isabelle Golbaz
Markus Ritter
Matthias Bolz
Ulrike Mayr-Sponer
P304
P356
10.1016/J.OPHTHA.2013.12.029
P577
2014-03-28T00:00:00Z